Viking Therapeutics, Inc. Balance Sheet

Balance Sheet Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 3.04M15.44M14.54M22.12M302.31M284.26M256.50M210.66M168.53M368.49M908.32M
Current Assets
Cash & Equivalents 0.76M0.77M3.08M8.99M300.44M274.43M246.14M26.37M36.63M55.52M26.68M
Prepaid Assets 0.02M1.10M0.28M0.39M0.28M0.41M0.44M0.62M3.41M2.52M1.13M
Current Assets 0.77M15.20M13.97M21.85M302.13M283.50M256.10M210.53M167.04M367.23M907.22M
Non-Current Assets
Other Non-Current Assets 2.27M0.08M0.04M0.03M0.03M0.03M0.03M0.03M0.03M0.05M
Non-Current Assets 2.27M0.24M0.56M0.27M0.18M0.76M0.40M0.13M1.49M1.26M1.10M
Liabilities
Current Liabilities
Accounts Payables 1.83M0.59M1.20M1.53M0.96M2.43M3.99M1.44M8.53M7.51M9.81M
Notes Payables 0.30M2.50M3.27M3.45M
Payables 2.13M3.09M4.47M4.98M0.96M2.43M3.99M1.44M8.53M7.51M9.81M
Accumulated Expenses 0.08M0.18M0.03M0.02M
Other Accumulated Expenses 0.38M1.38M1.24M2.26M3.59M4.04M7.81M7.30M13.11M11.30M17.11M
Current Leases 0.30M0.33M0.03M0.30M0.32M0.49M
Total Current Liabilities 22.52M1.98M6.48M8.66M4.55M6.78M12.13M8.78M21.95M19.14M27.41M
Non-Current Liabilities
Convertible Debt 1.26M2.15M1.50M1.50M
Non-Current Deffered Revenue 0.03M0.02M0.01M
Operating Leases 0.36M0.03M1.26M0.94M0.63M
Other Non-Current Liabilities 0.18M
Total Non-Current Liabilities 2.65M4.74M0.02M0.01M0.36M0.03M1.26M0.94M0.63M
Liabilities
Total Liabilities 25.17M6.71M6.49M8.66M4.56M7.14M12.16M8.78M23.21M20.07M28.04M
Shareholder's Equity
Common Equity -22.13M8.72M8.04M13.46M297.75M277.12M244.34M201.88M145.32M348.42M880.28M
Shareholder's Equity -22.13M8.72M8.04M13.46M297.75M277.12M244.34M201.88M145.32M348.42M880.28M
Liabilities and Shareholders Equity 3.04M15.44M14.54M22.12M302.31M284.26M256.50M210.66M168.53M368.49M908.32M
Treasury Shares 2.02M0.67M0.31M0.25M0.18M0.35M0.68M1.03M2.19M2.19M
Retained Earnings -22.14M-45.55M-60.28M-80.86M-102.92M-128.70M-168.19M-223.18M-292.05M-377.94M-487.91M
Shares Outstanding 6.00M9.68M20.82M35.82M71.74M72.41M73.22M78.25M78.26M100.11M111.57M